Comparative Pharmacology
Head-to-head clinical analysis: FLOXIN OTIC versus OTICAIR.
Peer-Reviewed Evidence
Head-to-head clinical analysis: FLOXIN OTIC versus OTICAIR.
FLOXIN OTIC vs OTICAIR
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Ofloxacin, a fluoroquinolone, inhibits bacterial DNA gyrase and topoisomerase IV, preventing DNA replication and transcription.
Ciprofloxacin inhibits bacterial DNA gyrase and topoisomerase IV, disrupting DNA replication; fluocinolone acetonide is a corticosteroid that induces phospholipase A2 inhibitory proteins, reducing prostaglandin and leukotriene synthesis, thereby suppressing inflammation.
Instill 5 drops (0.5 mL) into affected ear(s) twice daily for 10-14 days; for acute otitis externa, may use 5 drops twice daily for 7 days.
1-2 sprays into each affected ear twice daily for 7 days. Topical route.
None Documented
None Documented
6-8 hours in adults with normal renal function; prolonged to 30-50 hours in severe renal impairment (CrCl <20 mL/min).
4.2 hours; prolonged in renal impairment (up to 12 hours in creatinine clearance <30 mL/min)
Primarily excreted unchanged in urine via glomerular filtration and tubular secretion (70-80%); non-renal elimination (hepatic metabolism and biliary secretion) accounts for 20-30%.
Renal: 85% unchanged; biliary/fecal: 10%
Category C
Category C
Otic Antibiotic
Otic Antibiotic/Corticosteroid